{
  "ticker": "LLY",
  "target_date": "2025-01-03",
  "actual_date": "2025-01-03",
  "collected_at": "2025-12-08T11:14:00.662746",
  "price": {
    "open": 772.41,
    "high": 780.02,
    "low": 769.79,
    "close": 776.1904907226562,
    "volume": 1799100,
    "change_1d_pct": 0.5,
    "change_7d_pct": -1.8,
    "change_30d_pct": 7.16
  },
  "technicals": {
    "rsi_14": 49.83,
    "sma_20": 781.46,
    "sma_50": 794.0,
    "macd": -6.399,
    "macd_signal": -7.346,
    "macd_histogram": 0.947,
    "bb_upper": 817.34,
    "bb_lower": 745.58,
    "price_vs_sma20_pct": -0.67,
    "price_vs_sma50_pct": -2.24,
    "volume_ratio": 0.59
  },
  "fundamentals": {
    "market_cap": 891564326912,
    "pe_ratio": 48.728195,
    "forward_pe": 43.889782,
    "price_to_book": 37.445126,
    "price_to_sales": 15.004499,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.56,
    "pct_from_52w_low": 59.44
  },
  "macro": {
    "spy": {
      "price": 586.81,
      "change_1d_pct": 1.25,
      "change_7d_pct": -1.55
    },
    "vix": {
      "level": 16.13,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.6
    },
    "dollar_index": {
      "level": 108.95
    },
    "gold": {
      "price": 2645.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly & Co. stock rises Friday, still underperforms market",
      "source": "MarketWatch",
      "datetime": 1735921980,
      "summary": "Eli Lilly & Co. stock rises Friday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=60af084ee41a8446314cea80f0fcf5c664bddb918921bc66899cbb7c71b178e7"
    },
    {
      "headline": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
      "source": "Yahoo",
      "datetime": 1735912821,
      "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=d97093db5a279d85d4704528595e030be266375e2e58707cefc4538c9a077b4e"
    },
    {
      "headline": "From Davids to Goliaths: the GLP-1R gold rush",
      "source": "Yahoo",
      "datetime": 1735910418,
      "summary": "There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.",
      "url": "https://finnhub.io/api/news?id=f0597190b847720f110eaa96df6726d5a1290b22bc3d12947dfe474ff30ab385"
    },
    {
      "headline": "Amphastar Pharmaceuticals: Cheap With Caveats",
      "source": "SeekingAlpha",
      "datetime": 1735908513,
      "summary": "Amphastar Pharmaceuticals' stock has declined over 25% since early November, despite solid earnings and sales growth. Click here to find out why AMPH is a Hold.",
      "url": "https://finnhub.io/api/news?id=3d86ce0fb7e8ef8e751735952af173a8e96efbd368af54b2a60f25a0f6e21d3c"
    },
    {
      "headline": "Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'",
      "source": "Yahoo",
      "datetime": 1735908383,
      "summary": "As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA. The court has now ordered the Outsourcing Facilities Association to respond by January 15, with Eli L",
      "url": "https://finnhub.io/api/news?id=adaf8a9be9e6a0766d277dcafaac93719395e3d869b3aa5502c97bfdba500a90"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470180.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}